Skip to main
VTGN
VTGN logo

VistaGen Therapeutics (VTGN) Market Capitalization Overview

Market Cap: $87.20M as of Aug 1, 2025

$87.20M
Past Month+$28.59M (48.77%)
As of Aug 1, 2025, VistaGen Therapeutics (VTGN) has a market capitalization of $87.20M. Over the past 30 days, its market cap has increased by 48.77%, while in the last 12 months, it has increased by 6.15%.

Market capitalization represents the total value of VistaGen Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

VistaGen Therapeutics (VTGN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of VistaGen Therapeutics (VTGN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

VistaGen Therapeutics (VTGN) Market Cap History

DateMarket CapChange
Aug 1, 2025$87.20M+48.77%
Jul 1, 2025$58.61M-16.26%
Jun 2, 2025$69.99M+2.75%
May 1, 2025$68.12M+0.85%
Apr 1, 2025$67.54M-6.02%
Mar 3, 2025$71.87M-11.30%
Feb 3, 2025$81.03M-12.22%
Jan 2, 2025$92.31M+17.14%

VistaGen Therapeutics (VTGN) End of Year Market Cap History

DateMarket CapChange
2025$87.20M+6.15%
2024$82.14M-40.86%
2023$138.90M+551.98%
2022$21.31M-94.71%
2021$402.70M+49.69%
2020$269.01M

FAQs About VistaGen Therapeutics (VTGN) Market Cap

As of Aug 1, 2025, the market capitalization of VistaGen Therapeutics (VTGN) is $87.20M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, VistaGen Therapeutics’s market capitalization has increased by 48.77%, changing from $58.61M to $87.20M as of Aug 1, 2025.

In the last 3 months, VistaGen Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, VistaGen Therapeutics’s market capitalization decreased from $138.90M in January to $82.14M in December, reflecting a -40.86% change.

In the past five years, VistaGen Therapeutics (VTGN) has had a compound annual growth rate (CAGR) of -21.12% in market capitalization. This means its market cap has shrunk at an average rate of -21.12% per year.

VistaGen Therapeutics (VTGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.